TFMPP, a 5HT1B receptor agonist, inhibits light-induced phase shifts of the circadian activity rhythm and c-Fos expression in the mouse suprachiasmatic nucleus. [electronic resource]
- Neuroscience letters Aug 1997
- 95-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't